Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (6)
- (-) Climate Change (2)
- (-) Computer Science (8)
- (-) Energy Storage (1)
- (-) Environment (4)
- (-) Mathematics (1)
- (-) Nanotechnology (4)
- (-) National Security (2)
- (-) Neutron Science (4)
- (-) Security (3)
- (-) Transportation (1)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (3)
- Big Data (2)
- Bioenergy (1)
- Biology (2)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (1)
- Coronavirus (7)
- Cybersecurity (2)
- High-Performance Computing (1)
- Isotopes (4)
- Machine Learning (3)
- Materials (2)
- Materials Science (4)
- Mercury (1)
- Molten Salt (1)
- Nuclear Energy (2)
- Physics (1)
- Summit (4)
- Sustainable Energy (2)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Jeff Johnson, nonproliferation research and development integration manager for ORNL’s National Security Sciences Directorate, has been honored by the American Nuclear Society
From soda bottles to car bumpers to piping, electronics, and packaging, plastics have become a ubiquitous part of our lives.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Paul J. Hanson, ORNL Corporate Fellow, has been elected to the 2020 Class of Fellows of the American Geophysical Union.
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.